Jade Biosciences (JBIO) Other Non-Current Liabilities (2021 - 2025)
Jade Biosciences posted quarterly Other Non-Current Liabilities of $70000.0 for Q1 2025, little changed year-on-year from $70000.0 in Q1 2024, and down 99.93% on a QoQ basis from $107.6 million in Q4 2024.
Jade Biosciences (JBIO) has 5 years of Other Non-Current Liabilities data on file, last reported at $70000.0 in Q1 2025.
- For the quarter ending Q1 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $70000.0; the trailing twelve-month figure through Mar 2025 stood at $70000.0 (changed 0.0% YoY), and the FY2024 full-year result was $107.6 million, up 153614.29% from the prior year.
- Other Non-Current Liabilities for Q1 2025 stood at $70000.0, down from $107.6 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $107.6 million in Q4 2024 and bottomed at $13000.0 in Q4 2021.
- The 5-year median for Other Non-Current Liabilities is $70000.0 (2023), against an average of $7.7 million.
- The widest annual swing landed in 2023, when Other Non-Current Liabilities declined 1.41%; it then jumped 153614.29% in 2024.
- A 5-year view of Other Non-Current Liabilities shows it stood at $13000.0 in 2021, then jumped by 446.15% to $71000.0 in 2022, then decreased by 1.41% to $70000.0 in 2023, then surged by 153614.29% to $107.6 million in 2024, then plunged by 99.93% to $70000.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $70000.0 (Q1 2025), $107.6 million (Q4 2024), and $70000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | 107.60 Mn |
| Sep 30, 2024 | 70,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 70,000.00 |
| Jun 30, 2023 | 69,000.00 |
| Mar 31, 2023 | 70,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Sep 30, 2022 | 13,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 13,000.00 |